Skip to main content
. 2019 Apr 3;234(11):20002–20012. doi: 10.1002/jcp.28597

Figure 3.

Figure 3

Expression of GNG7 related to clinical features according to patients’ clinicopathological characteristics. (a) The mutation in GNG7 gene in ccRCC patient genome was analyzed in three cohorts using the cBioPortal online platform. (b) GNG7 gene promoter methylation information in 293 ccRCC patients was obtained from MethHC web resource by analyzing The Cancer Genome Atlas (TCGA) database. UALCAN online platform analysis of normal versus primary tumor of GNG7 (c), and association between the expression of GNG7 and tumor grade (d), and tumor stage (e) were also performed. p < 0.05 was considered statistically significant. ccRCC: clear cell renal cell carcinoma [Color figure can be viewed at wileyonlinelibrary.com]